By analysing the immune response of a patient who showed exceptional response to the H3K27M peptide vaccine, the authors found CD4+ T cells as crucial drivers of this response, and pointed to mechanisms through which the T cells recognise and fight tumour cells. This evidence concerns the gene CD4 and neoplasm.